MEB worried by diclofenac
This article is powered by OTC Bulletin & The Rose Sheet
Executive Summary
Diclofenac’s availability as an OTC medicines in the Netherlands is under threat with the country’s medicines agency, the MEB, promising to carefully examine the findings of a recent study highlighting the drug’s cardiovascular risks.